Area of research
Nephrology · Molecular Biology
Research interest
Research interests include Renal Diseases and Glomerulopathies, Ion Transport and Channel Regulation, Genetic and Kidney Cyst Diseases, and Renal Transplantation Outcomes and Treatments.
Microvascular Inflammation of Kidney Allografts and Clinical Outcomes
Presentation and outcome in carriers of pathogenic variants in SLC34A1 and SLC34A3 encoding sodium-phosphate transporter NPT 2a and 2c
Validation of a prediction system for risk of kidney allograft failure in pediatric kidney transplant recipients: An international observational study
Oral Coenzyme Q10 supplementation leads to better preservation of kidney function in steroid-resistant nephrotic syndrome due to primary Coenzyme Q10 deficiency
Variation of the clinical spectrum and genotype-phenotype associations in Coenzyme Q10 deficiency associated glomerulopathy
Clinical and genetic characteristics of Dent's disease type 1 in Europe
Refining genotype–phenotype correlations in 304 patients with autosomal recessive polycystic kidney disease and PKHD1 gene variants
Early childhood height-adjusted total kidney volume as a risk marker of kidney survival in ARPKD
Aetiology, course and treatment of acute tubulointerstitial nephritis in paediatric patients: a cross-sectional web-based survey
Severe neurological outcomes after very early bilateral nephrectomies in patients with autosomal recessive polycystic kidney disease (ARPKD)
Safety and efficacy of sucroferric oxyhydroxide in pediatric patients with chronic kidney disease
Outbreak of Shiga toxin-producing Escherichia coli (STEC) O26 paediatric haemolytic uraemic syndrome (HUS) cases associated with the consumption of soft raw cow’s milk cheeses, France, March to May 2019
Global Variation of Nutritional Status in Children Undergoing Chronic Peritoneal Dialysis: A Longitudinal Study of the International Pediatric Peritoneal Dialysis Network
Treatment and long-term outcome in primary distal renal tubular acidosis
Clinical and Genetic Spectrum of Bartter Syndrome Type 3
Value of biomarkers for predicting immunoglobulin A vasculitis nephritis outcome in an adult prospective cohort
Eculizumab is a safe and effective treatment in pediatric patients with atypical hemolytic uremic syndrome
Pharmacokinetics and dosage individualization of ganciclovir and valganciclovir in an infant with nephrotic syndrome associated with cytomegalovirus infection